180 related articles for article (PubMed ID: 29861909)
1. Potent inhibition of miR-27a by neomycin-bisbenzimidazole conjugates.
Nahar S; Ranjan N; Ray A; Arya DP; Maiti S
Chem Sci; 2015 Oct; 6(10):5837-5846. PubMed ID: 29861909
[TBL] [Abstract][Full Text] [Related]
2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
3. Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.
Tran TPA; Poulet S; Pernak M; Rayar A; Azoulay S; Di Giorgio A; Duca M
RSC Med Chem; 2022 Mar; 13(3):311-319. PubMed ID: 35434630
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-27 Inhibits Adenovirus Infection by Suppressing the Expression of SNAP25 and TXN2.
Machitani M; Sakurai F; Wakabayashi K; Nakatani K; Tachibana M; Mizuguchi H
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356525
[TBL] [Abstract][Full Text] [Related]
5. Targeting C-myc G-quadruplex: dual recognition by aminosugar-bisbenzimidazoles with varying linker lengths.
Ranjan N; Arya DP
Molecules; 2013 Nov; 18(11):14228-40. PubMed ID: 24252993
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5.
Si L; Jia Y; Lin R; Jian W; Yu Q; Yang S
Arch Biochem Biophys; 2019 Jun; 668():9-15. PubMed ID: 31047870
[TBL] [Abstract][Full Text] [Related]
7. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
[TBL] [Abstract][Full Text] [Related]
8. miR-27 and miR-124 target AR coregulators in prostate cancer: Bioinformatics and in vitro analysis.
Jafari Najaf Abadi MH; Khorashadizadeh M; Zarei Jaliani H; Jamialahmadi K; Aghaee-Bakhtiari SH
Andrologia; 2022 Oct; 54(9):e14497. PubMed ID: 35700742
[TBL] [Abstract][Full Text] [Related]
9. miR-27a acts as an oncogene to regulate endometrial cancer progression by targeting USP46.
Hao L; Wang J
Int J Clin Exp Pathol; 2021; 14(6):720-725. PubMed ID: 34239673
[TBL] [Abstract][Full Text] [Related]
10. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
[TBL] [Abstract][Full Text] [Related]
12. MiR-27a Promotes Hemin-Induced Erythroid Differentiation of K562 Cells by Targeting CDC25B.
Wang D; Si S; Wang Q; Luo G; Du Q; Liang Q; Guo X; Zhang G; Feng J; Leng Z
Cell Physiol Biochem; 2018; 46(1):365-374. PubMed ID: 29590650
[TBL] [Abstract][Full Text] [Related]
13. Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.
Vo DD; Becquart C; Tran TPA; Di Giorgio A; Darfeuille F; Staedel C; Duca M
Org Biomol Chem; 2018 Aug; 16(34):6262-6274. PubMed ID: 30116813
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
15. miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.
Su C; Huang DP; Liu JW; Liu WY; Cao YO
Oncol Lett; 2019 Sep; 18(3):2825-2834. PubMed ID: 31452761
[TBL] [Abstract][Full Text] [Related]
16. MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors.
Li X; Xu M; Ding L; Tang J
J Cancer; 2019; 10(12):2836-2848. PubMed ID: 31258791
[TBL] [Abstract][Full Text] [Related]
17. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
Wan X; Huang W; Yang S; Zhang Y; Zhang P; Kong Z; Li T; Wu H; Jing F; Li Y
Int J Biochem Cell Biol; 2016 Oct; 79():249-260. PubMed ID: 27594411
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-27a promotes tumorigenesis in tongue squamous cell carcinoma by enhancing proliferation, migration and suppressing apoptosis.
Chen H; Dong Z; Chen Y; Cui Y; Song P; Yang K
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4557-4567. PubMed ID: 33912994
[TBL] [Abstract][Full Text] [Related]
19. Quercetin's Dual Mode of Action to Counteract the Sp1-miR-27a Axis in Colorectal Cancer Cells.
Fosso E; Leo M; Muccillo L; Mandrone VM; Di Meo MC; Molinario A; Varricchio E; Sabatino L
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627542
[TBL] [Abstract][Full Text] [Related]
20. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
You L; Pan L; Chen L; Gu W; Chen J
Cell Physiol Biochem; 2016; 39(1):253-65. PubMed ID: 27337099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
